Draft Evidence Report
Midwest CEPAC

PDF cover

This is not the most recent version of this material.
For an updated version, please see the relevant topic page.

Amyloidosis: Draft Evidence Report

ICER’s Draft Evidence Report on treatments for hereditary transthyretin-related amyloidosis, open to public comment until August 17, 2018 at 5pm ET. For more information on submitting a public comment, please visit our stakeholder engagement page.

View

View All Materials on this Topic or Go Back to View More Materials